6 results

• Freestyle Libre 2 Lawsuit Alleges Faulty Blood Sugar Readings Resulted in Near-Fatal DKA Event

  April 24, 2026

  Michael Adams

  A Louisiana woman has filed a product liability lawsuit alleging a Freestyle Libre 2 CGM provided false low or normal blood sugar readings, delaying treatment and leading to a near-fatal DKA event.

• FreeStyle Libre 3 Lawsuits Mount as FDA Issues Class I Glucose Monitor Recall

  February 5, 2026

  Michael Adams

  Federal health officials have issued a Class I recall of certain Abbott FreeStyle Libre 3 and Libre 3 Plus glucose monitor sensors after internal testing found the devices could display dangerously inaccurate low blood sugar readings for extended periods without alerting users.

• FDA Warns 3 Million FreeStyle Libre 3 and Libre 3 Plus Sensors Impacted by Massive Abbott Recall

  January 19, 2026

  Michael Adams

  Federal regulators announced a Class I recall of about 3 million Abbott FreeStyle Libre 3 and Libre 3 Plus sensors, as emerging lawsuits claim the faulty devices triggered unnecessary insulin use and dangerous hypoglycemia after multiple deaths were linked to inaccurate readings.

• Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings

  January 15, 2026

  Irvin Jackson

  A new Abbott CGM lawsuit seeks class action status for all those who purchased the FreeStyle Libre 3, which was recalled in November for providing inaccurate glucose data.

• Abbott Libre 3 Class Action Lawsuit Claims CGM Defects Could Result in Serious Injury

  January 8, 2026

  Irvin Jackson

  Two plaintiffs are pursuing a class action lawsuit against Abbott Laboratories after last year's recall of its Freestyle Libre 3 continuous glucose monitoring devices due to inaccurate readings.

• Abbott FreeStyle Libre 3 Recall Issued After Faulty Glucose Sensor Readings Linked to Multiple Deaths

  November 26, 2025

  Darian Hauf

  Abbott has issued a recall for about 3 million FreeStyle Libre 3 glucose sensors, warning that some units may report dangerously low glucose readings that could place users at serious risk.